Publications
5539 Results
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #352
- Year
- 2005
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9911
An update of a phase II trial of CHOP followed by tositumomab/iodine I-131 tositumomab (Bexxar) for front-line treatment of advanced stage, follicular lymphoma: Southwest Oncology Group Protocol 9911
- Journal / Conference
- New England Journal of Medicine 352(25):2589-2597
- Year
- 2005
- Research Committee(s)
- Lung
- Study Number(s)
- JBR10
Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer
- Journal / Conference
- Proc of the ASCO, JCO 23(16S):3s (#7)
- Year
- 2005
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with matastatic GI Stromal tumors (GISTs) expressing KIT (KIT+)
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #2365
- Year
- 2005
- Research Committee(s)
- Leukemia
Very late antigen-4 (VLA-4) expression by AML blasts: correlation of VCAM-1 binding to overall survival
- Journal / Conference
- Journal of Clinical Oncology 23(33):8447-8452
- Year
- 2005
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7426/7427, SWOG-7713/14, SWOG-8809, S9800, S9911
New treatment options have changed the survival of patients with follicular lymphoma
- Journal / Conference
- Journal of Clinical Oncology 23(15):3562-3567
- Year
- 2005
- Research Committee(s)
- Head and Neck
- Study Number(s)
- E1395
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #1218
- Year
- 2005
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120
Gene expression profiling of bulk CD138+ plasma cells in preneoplastic gammopathy/asymptomatic myeloma identifies distinct subsets of patients
- Journal / Conference
- Breast Cancer Research and Treatment 94(Suppl 1):S6(#3)
- Year
- 2005
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/E2100
A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100)
- Journal / Conference
- Breast Cancer Research and Treatment 94(Suppl 1):S96(#2038)
- Year
- 2005
- Research Committee(s)
- Breast
- Study Number(s)
- N9831
Exploratory analysis from NCCTG N9831: do clinical and laboratory characteristics predict cardiac toxicity of trastuzumab when administered as a component of adjuvant therapy?
- Journal / Conference
- Breast Cancer Research and Treatment 94(Suppl 1):S50(#1035)
- Year
- 2005
- Research Committee(s)
- Breast
- Study Number(s)
- S0102